Pulmonary hypertension in Latin America: Pulmonary vascular disease: The global perspective

Chest

Volumn 137, Issue 6 SUPPL., 2010, Pages 78S-84S

  Lopes, Antonio Augusto ^a   Bandeira, Angela Pontes ^b   Flores, Patricia Cortez ^c   Santana, Maria Virginia Tavares ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Department of Pediatric Cardiology   (Ecuador)

^d INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; SILDENAFIL;

ALTITUDE; BRAZIL; CLINICAL TRIAL; CONGENITAL HEART DISEASE; ENDEMIC DISEASE; HEART LEFT RIGHT SHUNT; HUMAN; LUNG EDEMA; MEDICAL EDUCATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RACE DIFFERENCE; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA; TERTIARY HEALTH CARE;

EID: 77953314775     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2960     Document Type: Review

References (34)

1. Lizcano Fernández F. Composición Étnica de las Tres Áreas Culturales del Continente American al Comienzo del Siglo XXI [in Spanish]. Convergencia. 2005;38 :185-232.
2. National Population Council. Mexico City metropolitan area [in Spanish]. http://www.edomex.gob.mx/poblacion/docs/2009/PDF/ZMVM.pdf. Accessed May 4, 2010.
3. Greater São Paulo [in Portuguese]. http://www.planejamento.sp.gov. br/des/textos8/RMSP.pdf. Accessed May 4, 2010.
4. Population projections [in Spanish]. http://www.indec.mecon.ar/nuevaweb/ cuadros/2/estimaciones-serie34.pdf. Accessed May 4, 2010.
5. Gobierno de Chile Ministerio de Salud. Augumenta el número de chilenos atendidos en el sector publico de salud. http://www.redsalud.gov.cl/ noticias/noticias.php?id-n=96. Accessed March 19, 2010.
6. Brazil. Health indicators [in Portuguese]. http://portal.saude.gov.br/ portal/arquivos/pdf/painel-%20indicadores-do-SUS.pdf. Accessed March 19, 2010.
7. Brazil. Health indicators [in Portuguese]. http://tabnet.datasus.gov.br/ cgi/tabcgi.exe?idb2008/f16.def. Accessed March 19, 2010.
8. World Health Organization. Schistosomiasis: countries x indicators. http://www.who.int/neglected-diseases/preventive-chemotherapy/sch/db/index.html. Accessed March 19, 2010.
9. Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 2007;115(9):1132-1146.
10. Lopes AA, Rabinovitch M. eds. Statements of management on pulmonary hypertension associated with congenital heart disease. Cardiol Young 2009; 19(E-suppl 1):1-53.
11. Andrade ZA, Andrade SG. Pathogenesis of schistosomal pulmonary arteritis. Am J Trop Med Hyg. 1970;19(2):305-310.
12. Guimarães A, Guimarães I. Pulmonary schistosomiasis. In: Sharma OP, ed. Lung Disease in the Tropics. New York, NY: Marcel Dekker; 1991:319-340.
13. Bertrand E, Dalger J, Ramiara JP, Renambot J, Attia Y. L'hypertension arterielle pulmonare bilharzienne. Etude cliunique et hemodinamique chez 37 malades. Arch Mal Couer Vaiss. 1978;71(2):216-221.
14. Guimarães AC. Present state of knowledge of cardiopulmonary involvement in schistosomiasis mansoni [in Portuguese]. Arq Bras Cardiol. 1982;38(4):301-309.
15. Lapa M, Dias B, Jardim C, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation. 2009;119(11):1518-1523.
16. León-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147-157.
17. Heath D, Smith P, Rios Dalenz J, Williams D, Harris P. Small pulmonary arteries in some natives of La Paz, Bolivia. Thorax. 1981;36(8):599-604.
18. Heath D. Missing link from Tibet. Thorax. 1989;44(12):981-983.
19. Arias-Stella J, Saldaña M. The terminal portion of the pulmonary arterial tree in people native to high altitudes. Circulation. 1963;28 :915-925.
20. Penaloza D, Sime F, Ruiz L. Pulmonary hemodynamics in children living at high altitudes. High Alt Med Biol. 2008;9(3):199-207.
21. Maggiorini M, Mélot Ch, Pierre S, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 2001;103(16):2078-2083. (Pubitemid 32373011)
22. Maggiorini M. High altitude-induced pulmonary oedema. Cardiovasc Res. 2006;72(1):41-50.
23. Wu TY, Miao CY, Lin C, et al. Altitude illness in children on the Tibetan plateau. In: Ohno H, Kobayashi T, Masuyama S, Nakashima M, eds. Progress in Mountain Medicine and High Altitude Physiology. Matsumoto, Japan: Dogura and Co; 1998:195-200.
24. da Silva CH. Rheumatic fever: a multicenter study in the state of São Paulo. Pediatric Committee - São Paulo Pediatric Rheumatology Society. Rev Hosp Clin Fac Med Sao Paulo. 1999;54(3):85-90.
25. Sime F, Banchero N, Penaloza D, Gamboa R, Cruz J, Marticorena E. Pulmonary hypertension in children born and living at high altitudes. Am J Cardiol. 1963;11(2):143-149.
26. Huicho L, Niermeyer S. Cardiopulmonary pathology among children resident at high altitude in Tintaya, Peru: a cross-sectional study. High Alt Med Biol. 2006;7(2):168-179.
27. Huicho L. Postnatal cardiopulmonary adaptations to high altitude. Respir Physiol Neurobiol. 2007;158(2-3):190-203.
28. Miao C-Y, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol. 1988;12(1):224-228.
29. Chen QH, Wang XQ, Qi SG. Cross-sectional study of congenital heart disease among Tibetan children aged from 4 to 18 years at different altitudes in Qinghai Province. Chin Med J (Engl). 2008;121(24):2469-2472.
30. Peñaloza D, Arias-Stella J, Sime F, Recavarren S, Marticorena E. The heart and pulmonary circulation in children at high altitudes: physiological, anatomical and clinical observations. Pediatrics. 1964;34(4):568-582.
31. Galiè N, Ghofrani HA, Torbicki A, et al;Sildenafil Use in Pulmonary Arterial Hypertension(SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353(20):2148-2157.
32. Barst RJ, Langleben D, Frost A, et al; STRIDE-1 Study Group. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;169(4):441-447.
33. Galiè N, Rubin Lj, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008;371(9630):2093-2100.
34. Public consult n. 8, February 25, 2010. http://in.gov.br/imprensa/ visualiza/index.jsp?data=01/03/2010&jornal=1&pagina=82& totalArquivos=144. Accessed March 19, 2010.